Targeting histone deacetylase in thyroid cancer. - Wikidata - wikimedia - TriplyDB

Targeting histone deacetylase in thyroid cancer.

Targeting histone deacetylase in thyroid cancer.

http://www.wikidata.org/entity/Q38066990

about

Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer Proteomic-coupled-network analysis of T877A-androgen receptor interactomes can predict clinical prostate cancer outcomes between White (non-Hispanic) and African-American groups Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells.Histone Deacetylases Inhibitors in the Treatment of Retinal Degenerative Diseases: Overview and Perspectives MCM5 as a target of BET inhibitors in thyroid cancer cells Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine.Synergy between HDAC and PARP Inhibitors on Proliferation of a Human Anaplastic Thyroid Cancer-Derived Cell Line.Cooperation of histone deacetylase inhibitors SAHA and valproic acid in promoting sodium/iodide symporter expression and function in rat Leydig testicular carcinoma cells.Clinical significance of histone deacetylase (HDAC)-1, HDAC-2, HDAC-4, and HDAC-6 expression in human malignant and benign thyroid lesions.

P2860

Q33566645-407FD2F0-6710-4DE9-88A0-515C2511C58E Q33603806-9B3B1E46-6EAC-4F5C-B644-014C49C6615D Q34542337-C4F21C75-D901-4B5B-B555-F95FD368695B Q35691776-751A2428-21A7-4103-866D-54A72FB4C39F Q35744910-41109362-1830-47BA-AE87-D5230CA039A2 Q36965945-547E2D96-4D8B-4497-92B4-D380F0E44635 Q38675367-48D444D7-575E-444A-8876-2B76B86A5C40 Q38907017-3B02B2E7-4E63-4D79-A28F-F8D04C525175 Q39157582-045F0BAE-6E5C-4675-98EF-06207A8905BA Q44852149-3673E78F-EA8E-479C-A72B-39C1DEB2D291

P2860

Targeting histone deacetylase in thyroid cancer.

http://www.wikidata.org/entity/Q38066990

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Targeting histone deacetylase in thyroid cancer.

@en

type

label

Targeting histone deacetylase in thyroid cancer.

@en

prefLabel

Targeting histone deacetylase in thyroid cancer.

@en

P1433

Q38066990-11E07B7D-266B-434F-9ACD-DF456B1D76BB

P1476

Q38066990-292AC892-8811-4FE6-922C-C44098DD6074

P2093

Q38066990-1858C382-2DEC-4E6D-AC7E-247787C1989D

Q38066990-2FA49E9C-D88A-4D01-800E-DE98CCAC7DDE

Q38066990-37ACAFC8-ECBA-4414-97C0-04072ED2E3DD

Q38066990-92C104FE-192B-4D68-9783-3D35B78C701A

Q38066990-95F132F3-7689-4D9B-83AF-DD8C2006BE95

Q38066990-BAEB402E-044F-4705-AD3A-BB1FB216D8AA

P2860

Q38066990-07645002-A638-41E5-AF61-891011059A85

Q38066990-083B1229-4F17-43ED-A973-E89B1185CF9A

Q38066990-087CC6E5-F99F-4083-B4F0-34BD39823A94

Q38066990-08AC67DA-E122-455F-B2BF-E138ED12FCAD

Q38066990-09CDA762-60AA-453D-9AE8-8262937F3D82

Q38066990-0BFC000F-B337-4C93-8B5B-88C002357E0D

Q38066990-0E3B84A3-E382-4797-914E-87834FF085C1

Q38066990-1184009D-C2BE-4AE6-A9B1-8A4552D46412

Q38066990-13135D1A-1AF1-4DAA-A918-1E3CDAD21C39

Q38066990-132F8522-7A4B-406B-AD47-BF698BFD36E0

P304

Q38066990-7FAB6719-9713-4A6D-B250-18FF0588A56D

P31

Q38066990-75F85A7F-EE6B-4599-9634-7282B2293F7E

Q38066990-9232b4b7-486a-40d4-9ac4-b89e70e6a535

P356

Q38066990-23A7195B-ACB5-41C2-AA3D-6FE5773A533E

P407

Q38066990-8D7F8117-A60D-414F-8FFF-B2CDC5B4C032

P433

Q38066990-759D9501-AF71-4871-A4F4-BA15895666C2

P478

Q38066990-47C9F7E6-5D62-4873-94B7-4DF67C461B28

P50

Q38066990-90EB1BDB-8800-4194-9F71-FE9990F3CB2D

P577

Q38066990-FEC71EFA-7A15-47E9-A470-A8A0115B7844

P698

Q38066990-60E55AE2-7582-4AF2-B34B-B4B2348E2BF2

P356

14728222.2013.740013

P1433

Expert Opinion on Therapeutic Targets

P1476

Targeting histone deacetylase in thyroid cancer

@en

P2093

Cinzia Puppin

http://www.w3.org/2001/XMLSchema#string

Diego Russo

http://www.w3.org/2001/XMLSchema#string

Efisio Puxeddu

http://www.w3.org/2001/XMLSchema#string

Giuseppe Damante

http://www.w3.org/2001/XMLSchema#string

Sebastiano Filetti

http://www.w3.org/2001/XMLSchema#string

Stefania Bulotta

http://www.w3.org/2001/XMLSchema#string

P2860

The role of HDAC6 in cancer

HDAC6 is a microtubule-associated deacetylase

The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress

Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers

Reactivation of suppressed RhoB is a critical step for the inhibition of anaplastic thyroid cancer growth

Cytotoxic effects of gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells

Chromatin modifications and their function

The complex language of chromatin regulation during transcription

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

P304

179-193

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.2013.740013

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23234477

http://www.w3.org/2001/XMLSchema#string